Free Trial

Dermata Therapeutics (DRMAW) SEC Filings & 10K Form

$0.01
0.00 (0.00%)
(As of 11/5/2024 ET)

Recent Dermata Therapeutics SEC Filings

DateFilerForm TypeView
09/27/2024
4:00 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
09/24/2024
11:15 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form EFFECT
09/24/2024
3:16 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form 424B3
09/19/2024
3:46 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
09/17/2024
4:25 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
3:49 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/14/2024
11:15 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form EFFECT
06/07/2024
4:09 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form 424B5
06/07/2024
4:11 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2024
8:02 AM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2024
3:06 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
8:00 AM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
8:16 AM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2024
3:39 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form ARS
03/26/2024
3:31 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form DEFA14A
03/26/2024
3:26 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form DEF 14A
02/14/2024
2:35 PM
ARMISTICE CAPITAL, LLC (Filed by)
Dermata Therapeutics, Inc. (Subject)
Dermata Therapeutics (Subject)
Form SC 13G
01/12/2024
3:06 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2024
8:00 PM
Bedoya-Toro Munera Maria E (Reporting)
Dermata Therapeutics, Inc. (Issuer)
Dermata Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
8:00 PM
Dermata Therapeutics, Inc. (Issuer)
Dermata Therapeutics (Issuer)
Van Hoose Kyri K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
8:00 PM
Bradrick Brittany (Reporting)
Dermata Therapeutics, Inc. (Issuer)
Dermata Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
8:00 PM
Dermata Therapeutics, Inc. (Issuer)
Dermata Therapeutics (Issuer)
HALE DAVID F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
8:01 PM
Dermata Therapeutics, Inc. (Issuer)
Dermata Therapeutics (Issuer)
WIERENGA WENDELL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
8:01 PM
Dermata Therapeutics, Inc. (Issuer)
Dermata Therapeutics (Issuer)
Nardo Christopher J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
8:01 PM
Dermata Therapeutics, Inc. (Issuer)
Dermata Therapeutics (Issuer)
Sandler Andrew Seth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
8:01 PM
Dermata Therapeutics, Inc. (Issuer)
Dermata Therapeutics (Issuer)
Scott Kathleen D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
8:02 PM
Dermata Therapeutics, Inc. (Issuer)
Dermata Therapeutics (Issuer)
FISHER MARY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
8:02 PM
Dermata Therapeutics, Inc. (Issuer)
Dermata Therapeutics (Issuer)
PROEHL GERALD T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
8:04 PM
Dermata Therapeutics, Inc. (Issuer)
Dermata Therapeutics (Issuer)
Mento Steven J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2023
11:15 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form EFFECT
12/08/2023
4:29 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form DEF 14A
11/29/2023
4:16 PM
Dermata Therapeutics, Inc. (Filer)
Dermata Therapeutics (Filer)
Form PRE 14A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:DRMAW) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners